Introduction to longevity research

Longevity research is a multidisciplinary field of science that has the potential to profoundly change human life. It is concerned with the biological, genetic and technological processes that influence ageing and health in old age. While the original aim of longevity research was to combat age-related diseases, the focus is increasingly expanding to extend lifespan and improve quality of life over a long period of time. This progress is referred to as "healthy longevity" or "healthspan", i.e. the time during which people can lead a healthy, functional life.

The biological basis of ageing

Understanding the biological mechanisms that drive ageing is central to longevity research. Biogerontology, a key area of this research, investigates the molecular and cellular processes associated with ageing. A central concept is cell aging, also known as senescence, in which cells lose their ability to divide and remain in the tissue, causing inflammation and tissue damage. Another central theory is the shortening of telomeres, the protective ends of chromosomes, which shorten with each cell division and ultimately induce cell death.

Cell biology and molecular biology also play a central role, as these disciplines investigate the mechanisms at the cellular level and the regulation of genes and proteins that influence ageing. These processes are crucial for the development of therapeutic approaches to slow down or reverse cell ageing. One example is DNA repair, a natural process that protects cells from damage caused by oxidative stress and other age-related factors. As we age, this repair capacity decreases, leading to the accumulation of cell damage.

Genetics and epigenetics in the ageing process

Genetics and epigenetics have a significant influence on lifespan and the ageing process. Genetic research has shown that certain genes can accelerate or slow down ageing. Through the use of gene editing technologies such as CRISPR/Cas9, scientists can modify genes associated with age-related diseases, increasing the potential for an extended lifespan. While genetics studies the structure and function of genes, epigenetics is concerned with the chemical changes that control the activity of genes without altering the DNA sequence. Epigenetic markers, such as DNA methylation, influence how genes are activated or deactivated throughout life. The epigenetic state can be altered by environmental and lifestyle factors, leading to new opportunities for "reprogramming" to reset the biological clock.

Regenerative medicine and nanotechnology

A central aspect of longevity research is regenerative medicine, which aims to restore and renew tissues and organs that have been damaged over time. Stem cell therapies play a crucial role here, as stem cells are able to transform into any type of cell and thus repair degenerated tissue. In combination with 3D bioprinting, a technique that makes it possible to grow tissue and organs in the laboratory, regenerative medicine could provide long-term cures for age-related diseases such as heart disease, osteoporosis and kidney disease. These technologies are still in the development phase, but show enormous potential to slow down ageing and improve quality of life in old age.

Another promising area is nanotechnology, which works at a molecular level to combat diseases and repair cell damage. Nanoparticles can deliver drugs precisely to diseased cells, making the treatment of age-related diseases more effective and with fewer side effects. The targeted delivery of active substances using nanotechnology offers a way to slow down specific ageing processes by reducing inflammation or removing senescent cells in a targeted manner.

Pharmacological interventions

Pharmacology also plays an important role in longevity research. The focus here is on the development of drugs that can slow down or even reverse the ageing process. One promising area is research into senolytics, a class of drugs aimed at eliminating senescent cells that accelerate the ageing process and promote chronic inflammation. By specifically removing these cells, it may be possible to improve the quality of life in old age and delay age-related diseases.

Another approach is NAD+ boosters, which support cellular energy metabolism. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that plays an important role in energy production in cells and DNA repair. With increasing age, the NAD+ level in the body decreases, which leads to a deterioration in cell function. Increasing NAD+ levels could slow down the ageing process and improve cell function.

Neurosciences and cardiology

In addition to combating diseases that accelerate ageing, neuroscience and cardiology also play a central role in longevity research. Age-related neurodegenerative diseases such as Alzheimer's and Parkinson's represent one of the greatest challenges. Neuroscientific approaches such as brain-computer interfaces (BCIs) and brain implants could in future help to treat neurological diseases or regenerate the brain and thus preserve cognitive abilities.

Cardiology, on the other hand, is investigating how cardiovascular diseases, one of the main causes of death worldwide, can be better treated and prevented. Innovative interventions, such as improving heart health at a cellular level, could significantly extend lifespan.

Artificial intelligence and bioethics

With increasing progress in longevity research, the use of artificial intelligence (AI) and data analysis is becoming more and more important. AI makes it possible to analyze large amounts of health and genomic data to identify patterns and potential interventions in the aging process. Personalized health strategies based on individual genetic and epigenetic profiles could enable age-related diseases to be predicted and treated more effectively.

In addition to scientific and technological issues, bioethics is also of central importance. The ethical and social questions arising from longevity research are numerous: Who will have access to life-prolonging technologies? How will society change if people live significantly longer? These and many other questions need to be considered in research and policy-making to ensure that new technologies are used fairly and responsibly.